James Byrne, M.D., Ph.D.
MIT
James is at the Koch Institute at MIT in the laboratories of Robert Langer, Sc.D., and Giovanni Traverso, M.B., B.Chir., Ph.D. His research aims to generate novel radioprotectants to improve radiation treatments in hard-to-treat cancers. He received his B.S. in Biomedical Engineering at the University of Texas at Austin and M.D. and Ph.D. from the University of North Carolina in Chapel Hill.

Nikki Lytle, Ph.D.
Salk Institute
Nikki is in the Geoffrey Wahl Lab at The Salk Institute for Biological Studies. Her project focuses on uncovering therapeutic approaches for preventing metastatic progression in early-stage pancreatic cancer. She received her B.A. in Biology and Religious Studies from Willamette University, and her Ph.D. in Biomedical Sciences from the University of California San Diego.

Nitin Shirole, Ph.D.
Dana-Farber Cancer Institute
Nitin is in the Laboratory of Dr. Willam G. Kaelin, Jr. at Howard Hughes Medical Institute/Dan-Farber Cancer Institute. The aim of his research is to understand why kidney cancer cells are dependent on paralogous protein function. He received his B.Sc. in Biotechnology from Nagpur University, M.S. in Cell and Molecular Biology from The University of Alabama, and Ph.D. in Genetics/Cancer Biology from Stony Brook University.
Dr. Shirole is the Hope Funds for Cancer Research Sakonnett Fellow